Sunshine Biopharma (SBFM) Current Assets (2010 - 2026)
Sunshine Biopharma's (SBFM) quarterly Current Assets came in at $24.8 million in Q1 2026, up 1.23% YoY from $24.5 million in Q1 2025, and down 7.71% on a QoQ basis from $26.9 million in Q4 2025.
Sunshine Biopharma (SBFM) Current Assets (2010 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 16 years of Current Assets data on file, last reported at $24.8 million in Q1 2026.
- Quarterly Current Assets rose 1.23% year-over-year to $24.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.8 million (up 1.23% YoY) and the FY2025 annual result came in at $26.9 million, up 3.42% from the prior year.
- Current Assets declined to $24.8 million in Q1 2026, from $26.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $42.0 million in Q2 2022 to a low of $13.4 million in Q1 2022.
- A 5-year average of $27.3 million and a median of $26.0 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets jumped 2228.1% — and 2023, when it tumbled 37.84%.
- Tracing SBFM's Current Assets over 5 years: stood at $27.3 million in 2022, then decreased by 8.87% to $24.9 million in 2023, then increased by 4.32% to $26.0 million in 2024, then climbed by 3.42% to $26.9 million in 2025, then retreated by 7.71% to $24.8 million in 2026.
- The last three Current Assets figures came in at $24.8 million (Q1 2026), $26.9 million (Q4 2025), and $28.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | 30.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.67 Mn |
| Mar 31, 2026 | 24.78 Mn |
| Dec 31, 2025 | 26.85 Mn |
| Sep 30, 2025 | 27.97 Mn |
| Jun 30, 2025 | 27.85 Mn |
| Mar 31, 2025 | 24.48 Mn |
| Dec 31, 2024 | 25.97 Mn |
| Sep 30, 2024 | 25.98 Mn |
| Jun 30, 2024 | 25.75 Mn |
| Mar 31, 2024 | 28.83 Mn |
| Dec 31, 2023 | 24.89 Mn |
| Sep 30, 2023 | 25.43 Mn |
| Jun 30, 2023 | 26.10 Mn |
| Mar 31, 2023 | 24.95 Mn |
| Dec 31, 2022 | 27.31 Mn |
| Sep 30, 2022 | 40.86 Mn |
| Jun 30, 2022 | 41.99 Mn |
| Mar 31, 2022 | 13.41 Mn |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | 2.49 Mn |